Published in Immunotherapy Weekly, February 8th, 2012
"Aggressive topical anti-inflammatory and mydriatic therapy did not break the pupillary membranes and the patient...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2012-02-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.